000 01316 a2200325 4500
005 20250516091805.0
264 0 _c20121231
008 201212s 0 0 spa d
022 _a1579-2021
024 7 _a10.1016/j.endonu.2012.03.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCapdevila, Jaume
245 0 0 _a[Neuroendocrine tumors: the age of targeted therapies].
_h[electronic resource]
260 _bEndocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion
_c
300 _a438-51 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Review
650 0 4 _aEverolimus
650 0 4 _aGastrointestinal Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aNeuroendocrine Tumors
_xdrug therapy
650 0 4 _aPancreatic Neoplasms
_xdrug therapy
650 0 4 _aSirolimus
_xanalogs & derivatives
700 1 _aArgilés, Guillem
700 1 _aMulet-Margalef, Nuria
700 1 _aTabernero, Josep
773 0 _tEndocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion
_gvol. 59
_gno. 7
_gp. 438-51
856 4 0 _uhttps://doi.org/10.1016/j.endonu.2012.03.003
_zAvailable from publisher's website
999 _c21761578
_d21761578